Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure
NCT00925470 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200
Last updated 2009-12-18
Summary
Evaluation of target organs impairment on patients suffering from high blood pressure without known cardio vascular or renal disease, stratified on blood pressure control.
Conditions
- Blood Pressure
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Alain Castaigne, Medical Director · AstraZeneca
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Completion
- 2009-12-31
Countries
- France
Study Locations
More Related Trials
-
Precision Treatment With Angiotensin Converting Enzyme Inhibitor
NCT05535595 ·Status: COMPLETED ·Phase: PHASE4
-
Analysis of Antihypertensive Treatment Efficacy
NCT00767247 ·Status: TERMINATED
-
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
NCT05732727 ·Status: RECRUITING ·Phase: PHASE3
-
Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension
NCT00971165 ·Status: COMPLETED ·Phase: PHASE3
-
National Survey on Hypertension in Cardiologic Private Practice
NCT00695175 ·Status: COMPLETED
-
National Survey on Hypertension in General Practitioner (GP) Consultation
NCT00695656 ·Status: COMPLETED
-
Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension
NCT02202525 ·Status: COMPLETED
-
Resistant Arterial Hypertension Cohort Study
NCT01083017 ·Status: COMPLETED
-
The TARGET BP OFF-MED Trial
NCT03503773 ·Status: COMPLETED ·Phase: PHASE2
-
Multi-center Study on New Cardiovascular Remodeling and Function Parameters in Hypertension
NCT05638503 ·Status: RECRUITING
-
Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy
NCT00295542 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Effect of Agiotensin-(1-7) in Healthy and Hypertensive Subjects
NCT03001271 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Nijmegen Antihypertensive Management Improvement Study
NCT00457483 ·Status: COMPLETED ·Phase: PHASE4
-
Predisposition and Transition Mechanisms From Arterial Hypertension to Heart Failure
NCT02430805 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular and Renal Outcomes of Integrated Management of Blood Pressure and Other Cardiometabolic Risks in Hypertensives
NCT04531124 ·Status: NOT_YET_RECRUITING
-
Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension
NCT02603809 ·Status: COMPLETED ·Phase: PHASE2
-
The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis
NCT01703780 ·Status: UNKNOWN
-
Ambulatory Blood Pressure in HFPEF Outcomes Global Registry
NCT04065620 ·Status: UNKNOWN
-
Non-invasive Haemodynamic Assessment in Hypertension
NCT01996085 ·Status: COMPLETED ·Phase: NA
-
Mechanisms of Anti-VEGF Induced Hypertension
NCT02156310 ·Status: COMPLETED
-
Emerging Biomarkers in Hypertension
NCT02064218 ·Status: UNKNOWN
-
Strategy for Preventing Cardiovascular and Renal Events Based on ARTErial Stiffness
NCT02617238 ·Status: UNKNOWN ·Phase: NA
-
Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two Drugs
NCT03560804 ·Status: COMPLETED ·Phase: NA
-
The Transition From Hypertension to Hypertensive Heart Disease and Heart Failure, the PREFERS Hypertension Study
NCT04190420 ·Status: ENROLLING_BY_INVITATION
-
From Micro- to Macro-vessels : Water, Salt, Heart and Kidneys
NCT05114291 ·Status: COMPLETED